Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type (Diagnostics Imaging (Sigmoidoscopy, Colonoscopy, Others), Stool Test (Guaiac FOBT, Fecal immunochemical Test (FIT), FIT-DNA Test), Biopsy (Image Guided Biopsy, Liquid Biopsy, Others), Others), By Application (Hospitals & Specialty Clinics, Ambulatory Care Ce
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationColorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type (Diagnostics Imaging (Sigmoidoscopy, Colonoscopy, Others), Stool Test (Guaiac FOBT, Fecal immunochemical Test (FIT), FIT-DNA Test), Biopsy (Image Guided Biopsy, Liquid Biopsy, Others), Others), By Application (Hospitals & Specialty Clinics, Ambulatory Care Ce
According to Global Cancer Observatory, in 2020, around 1,931,590 new colorectal cancer cases were reported worldwide among which the males and females accounted for 1,065,960 and 8,65,630 cases respectively in 2020.
. According to Statista Research Department, the estimated number of colorectal cancer cases among men and women in the United States in 2022 were around 117,910 and 1,18,830, respectively.
Increasing Incidence of Colorectal Cancer
as per American Cancer Society 2022, the number of cases is increasing around 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in United States.
Sedentary Lifestyle and rising awareness among individuals
According to the Centers for Disease Control and Prevention (CDC), around 15% adults are physically inactive, and do not participate in activities such as running, walking for exercise, or gardening.
Growth in Research & Development
According to Clinicaltrials.gov, 5213 clinical trials are in different phases of development across the globe for colorectal cancer
Market Segmentation
Global Colorectal Cancer Diagnostics Market can be segmented by diagnosis type, application, region and company. Based on diagnosis type, the market can be segmented into diagnostics imaging, stool test, biopsy, and others. Based on diagnostics imaging, the market is fragmented into sigmoidoscopy, colonoscopy, and others. Based on stool test, the market is fragmented into Guaiac FOBT, FIT, FIT-DNA Test. Based on biopsy, the market is fragmented into Image Guided Biopsy, Liquid Biopsy, and others. Based on application, the market is segmented into hospitals & specialty clinics, ambulatory care centers, and others.
Advancement in Technology and Product Launches
For instance, in January 2022, Clinical Genomics, a leading innovator of colorectal cancer testing, and Quest Diagnostics (NYSEDGX), the global leader in Diagnostics information services, announced a 5-year extension of their US supply agreement for the InSure ONE (FIT) fecal immunochemistry test.
Company Profiles
Abbott Laboratories, Illumina, Inc., Sysmex Corporation, Beckman Coulter, Siemens Healthineers AG, Quest Diagnostics, Danaher Corporation, Cancer Genetics Inc, Biocept Inc., Epigenomics AG, etc. are some of the key players operating in the global colorectal cancer diagnostics market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Diagnosis Type Application Region Company |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; Germany; France; United Kingdom; Spain; Italy; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; Africa; Turkey; Egypt |
| Key companies profiled | Abbott Laboratories, Illumina, Inc., Sysmex Corporation, Beckman Coulter, Siemens Healthineers AG, Quest Diagnostics, Danaher Corporation, Cancer Genetics Inc, Biocept Inc., Epigenomics A.G. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy